News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ProCertus BioPharm, Inc. Closes $2.3 Million Series A Financing Led by Venture Investors LLC


5/10/2007 12:27:39 PM

MADISON, Wis.--(BUSINESS WIRE)--ProCertus BioPharm, Inc., an oncology-based pharmaceutical company developing therapeutics to protect cancer patients against the side effects of chemotherapy and radiotherapy, has closed on a Series A Preferred Stock financing led by Venture Investors LLC (VI). VI was joined in the financing by existing investors, including Novartis Venture Fund (NVF).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES